World Wires · story 32584 · corroborated · 1 source(s)

Targeting ribosome biogenesis sensitizes PARPi-resistant triple-negative breast cancer

Poly (ADP-ribose) polymerase inhibitors (PARPi) are the only targeted treatment available for early triple-negative breast cancer (TNBC), an aggressive sub

Open in the desk

Coverage

• Targeting ribosome biogenesis sensitizes PARPi-resistant triple-negative breast cancer bioRxiv (new preprints) · tier C · clear net · 2026-10-09 00:00 UTC

What this site indexes